Modifications in Connexin Expression in Liver Development and Cancer

Cell Communication and Adhesion

Volumn 19, Issue 3-4, 2012, Pages 55-62

  Vinken, Mathieu ^a   De Kock, Joery ^a   Oliveira, André G ^b   Menezes, Gustavo B ^b   Cogliati, Bruno ^c   Dagli, Maria Lúcia Zaidan ^c   Vanhaecke, Tamara ^a   Rogiers, Vera ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Connexin; Gap; Hepatic differentiation; Hepatocarcinogenesis; Junction

Indexed keywords

BETA CAROTENE; BETA CATENIN; CONNEXIN 26; CONNEXIN 30; CONNEXIN 31; CONNEXIN 32; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CYTOCHROME P450; GAP JUNCTION PROTEIN; GLUCAGON; LIOTHYRONINE; RETINOL; S ADENOSYLMETHIONINE;

ARTERY ENDOTHELIUM; CANCER STEM CELL; CELL COMMUNICATION; CELL CYCLE; CELL DIFFERENTIATION; DISEASE ASSOCIATION; DOWN REGULATION; GAP JUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLYCOGENOLYSIS; HEPATIC ARTERY; HEPATITIS; HOMEOSTASIS; HUMAN; KUPFFER CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DEVELOPMENT; LIVER FIBROSIS; LIVER TOXICITY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; ONTOGENY; PHENOTYPE; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; STELLATE CELL; WNT SIGNALING PATHWAY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CONNEXINS; HUMANS; LIVER; LIVER NEOPLASMS;

EID: 84866329935     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2012.712576     Document Type: Review

References (86)

1. Belluardo N, White TW, Srinivas M, Trovato-Salinaro A, Ripps H, Mudo G, Bruzzone R, Condorelli DF (2001). Identifi cation and functional expression of HCx31.9, a novel gap junction gene. Cell Commun Adhes. 8 : 173-178.
2. Berthoud VM, Iwanij V, Garcia AM, Saez JC (1992). Connexins and glucagon receptors during development of rat hepatic acinus. Am J Physiol. 263 : G650-G658.
3. Bode HP, Wang L, Cassio D, Leite MF, St-Pierre MV, Hirata K, Okazaki K, Sears ML, Meda P, Nathanson MH, Dufour JF (2002). Expression and regulation of gap junctions in rat cholangiocytes. Hepatology. 36 : 631-640.
4. Chaytor AT, Martin PE, Edwards DH, Griffi th TM (2001). Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. Am J Physiol Heart Circ Physiol. 280 : H2441-H2450.
5. Cicirata F, Nicotra A, Cicero D, Parenti R, Zappala A (2004). Cloning and expression pattern of connexin39, a new member of the gap junction gene family isolated from the neural tube of chicken embryos. Gene. 328 : 121-126.
6. Cogliati B, Da Silva TC, Aloia TP, Chaible LM, Real-Lima MA, Sanches DS, Matsuzaki P, Hernandez-Blazquez FJ, Dagli ML (2011). Morphological and molecular pathology of CCL(4)-induced hepatic fi brosis in connexin43-defi cient mice. Microsc Res Tech. 74 : 421-429.
7. De Maio A, Gingalewski C, Theodorakis NG, Clemens MG (2000). Interruption of hepatic gap junctional communication in the rat during infl ammation induced by bacterial lipopolysaccharide. Shock. 14 : 53-59.
8. Decrock E, Vinken M, De Vuyst E, Krysko DV, D' Herde K, Vanhaecke T, Vandenabeele P, Rogiers V, Leybaert L (2009). Connexin-related signaling in cell death: to live or let die? Cell Death Differ. 16 : 524-536.
9. Elaut G, Henkens T, Papeleu P, Snykers S, Vinken M, Vanhaecke T, Rogiers V (2006). Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab. 7 : 629-660.
10. Evert M, Ott T, Temme A, Willecke K, Dombrowski F (2002). Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-defi cient mice. Carcinogenesis. 23 : 697-703.
11. Fitzgerald DJ, Mesnil M, Oyamada M, Tsuda H, Ito N, Yamasaki H (1989). Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis. J Cell Biochem. 41 : 97-102.
12. Gabriel HD, Jung D, Butzler C, Temme A, Traub O, Winterhager E, Willecke K (1998). Transplacental uptake of glucose is decreased in embryonic lethal connexin26-defi cient mice. J Cell Biol. 140 : 1453-1461.
13. Gaspers LD, Thomas AP (2005). Calcium signaling in liver. Cell Calcium. 38 : 329-342.
14. Gingalewski C, Wang K, Clemens MG, De Maio A (1996). Posttranscriptional regulation of connexin 32 expression in liver during acute infl ammation. J Cell Physiol. 166 : 461-467.
15. Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S, LeCluyse EL (2001). Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell Tissue Res. 306 : 85-99.
16. Ionta M, Ferreira RA, Pfi ster SC, Machado-Santelli GM (2009). Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. Cancer Cell Int. 9 : 22.
17. Iwai M, Harada Y, Muramatsu A, Tanaka S, Mori T, Okanoue T, Katoh F, Ohkusa T, Kashima K (2000). Development of gap junctional channels and intercellular communication in rat liver during ontogenesis. J Hepatol. 32 : 11-18.
18. Kaneda M, Zhang D, Bhattacharjee R, Nakahama K, Arii S, Morita I (2008). Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43. Cancer Lett. 263 : 53-60.
19. Kawasaki Y, Kubomoto A, Yamasaki H (2007). Control of intracellular localization and function of Cx43 by SEMA3F. J Membr Biol. 217 : 53-61.
20. Kawasaki Y, Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, Ishikawa K, Enomoto K (2011). Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal. Int J Cancer. 128 : 51-62.
21. Kojima T, Mitaka T, Shibata Y, Mochizuki Y (1995). Induction and regulation of connexin26 by glucagon in primary cultures of adult rat hepatocytes. J Cell Sci. 108 : 2771-2780.
22. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H (1994). Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer. 56 : 87-94.
23. Krutovskikh VA, Mesnil M, Mazzoleni G, Yamasaki H (1995). Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Lab Invest. 72 : 571-577.
24. Kumar NM, Gilula NB (1986). Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein. J Cell Biol. 103 : 767-776.
25. Laszlo V, Dezso K, Baghy K, Papp V, Kovalszky I, Safrany G, Thorgeirsson SS, Nagy P, Paku S (2008). Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes. Histochem Cell Biol. 130 : 1005-1014.
26. Leithe E, Sirnes S, Omori Y, Rivedal E (2006). Downregulation of gap junctions in cancer cells. Crit Rev Oncog. 12 : 225-256.
27. Li Q, Omori Y, Nishikawa Y, Yoshioka T, Yamamoto Y, Enomoto K (2007). Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo. Int J Cancer. 121 : 536-546.
28. Ma XD, Sui YF, Wang WL (2000). Expression of gap junction genes connexin 32, connexin 43 and their proteins in hepatocellular carcinoma and normal liver tissues. World J Gastroenterol. 6 : 66-69.
29. Ma XD, Ma X, Sui YF, Wang WL (2002). Expression of gap junction genes connexin32 and connexin43 mRNAs and proteins, and their role in hepatocarcinogenesis. World J Gastroenterol. 8 : 64-68.
30. Ma XD, Ma X, Sui YF, Wang WL, Wang CM (2003). Signal transduction of gap junctional genes, connexin32, connexin43 in human hepatocarcinogenesis. World J Gastroenterol. 9 : 946-950.
31. Mesnil M, Krutovskikh V, Omori Y, Yamasaki H (1995). Role of blocked gap junctional intercellular communication in nongenotoxic carcinogenesis. Toxicol Lett. 82-83 : 701-706.
32. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML (2005). Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta. 1719 : 125-145.
33. Mitchell JA, Lye SJ (2005). Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. Endocrinology. 146 : 2048-2054.
34. Naiki-Ito A, Asamoto M, Naiki T, Ogawa K, Takahashi S, Sato S, Shirai T (2010). Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol. 38 : 280-286.
35. Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N (2004). Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol. 39 : 763-768.
36. Nakata Y, Iwai M, Kimura S, Shimazu T (1996). Prolonged decrease in hepatic connexin32 in chronic liver injury induced by carbon tetrachloride in rats. J Hepatol. 25 : 529-537.
37. Nathanson MH, Rios-Velez L, Burgstahler AD, Mennone A (1999). Communication via gap junctions modulates bile secretion in the isolated perfused rat liver. Gastroenterology. 116 : 1176-1183.
38. Naves MM, Silveira ER, Dagli ML, Moreno FS (2001). Effects of beta-carotene and vitamin A on oval cell proliferation and connexin 43 expression during hepatic differentiation in the rat(1). J Nutr Biochem. 12 : 685-692.
39. Nelles E, Butzler C, Jung D, Temme A, Gabriel HD, Dahl U, Traub O, Stumpel F, Jungermann K, Zielasek J, Toyka KV, Dermietzel R, Willecke K (1996). Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-defi cient mice. Proc Natl Acad Sci USA. 93 : 9565-9570.
40. Neveu MJ, Babcock KL, Hertzberg EL, Paul DL, Nicholson BJ, Pitot HC (1994). Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res. 54 : 3145-3152.
41. Neveu MJ, Hully JR, Babcock KL, Vaughan J, Hertzberg EL, Nicholson BJ, Paul DL, Pitot HC (1995). Proliferationassociated differences in the spatial and temporal expression of gap junction genes in rat liver. Hepatology. 22 : 202-212.
42. Nicholson B, Dermietzel R, Teplow D, Traub O, Willecke K, Revel JP (1987). Two homologous protein components of hepatic gap junctions. Nature. 329 : 732-734.
43. Nielsen PA, Kumar NM (2003). Differences in expression patterns between mouse connexin-30.2 (Cx30.2) and its putative human orthologue, connexin-31.9. FEBS Lett. 540: 151-156.
44. Ohtake Y, Maruko A, Abe S, Nagashima T, Fukumoto M, Ohkubo Y (2006). Involvement of retinoic acid-induced transglutaminase activity in zonal differences of hepatocyte proliferation after partial hepatectomy. J Gastroenterol Hepatol. 21 : 1726-1730.
45. Ohtake Y, Maruko A, Ohishi N, Fukumoto M, Ohkubo Y (2008). Effect of aging on EGF-induced proliferative response in primary cultured periportal and perivenous hepatocytes. J Hepatol. 48 : 246-254.
46. Ott T, Jokwitz M, Lenhard D, Romualdi A, Dombrowski F, Ittrich C, Schwarz M, Willecke K (2006). Ablation of gap junctional communication in hepatocytes of transgenic mice does not lead to disrupted cellular homeostasis or increased spontaneous tumourigenesis. Eur J Cell Biol. 85 : 717-728.
47. Oyamada M, Krutovskikh VA, Mesnil M, Partensky C, Berger F, Yamasaki H (1990). Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Mol Carcinog. 3 : 273-278.
48. Oyamada M, Oyamada Y, Takamatsu T (2005). Regulation of connexin expression. Biochim Biophys Acta. 1719 : 6-23.
49. Paku S, Nagy P, Kopper L, Thorgeirsson SS (2004). 2-acetylaminofl uorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies. Hepatology. 39 : 1353-1361.
50. Paul DL (1986). Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol. 103 : 123-134.
51. Rosenberg E, Faris RA, Spray DC, Monfi ls B, Abreu S, Danishefsky I, Reid LM (1996). Correlation of expression of connexin mRNA isoforms with degree of cellular differentiation. Cell Adhes Commun. 4 : 223-235.
52. Rosenberg E, Spray DC, Reid LM (1992). Transcriptional and posttranscriptional control of connexin mRNAs in periportal and pericentral rat hepatocytes. Eur J Cell Biol. 59 : 21-26.
53. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC (2003). Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 83 : 1359-1400.
54. Saito T, Krutovskikh V, Marion MJ, Ishak KG, Bennett WP, Yamasaki H (2000). Human hemangiosarcomas have a common polymorphism but no mutations in the connexin37 gene. Int J Cancer. 86 : 67-70.
55. Sheen IS, Jeng KS, Shih SC, Kao CR, Wang PC, Chen CZ, Chang WH, Wang HY, Shyung LR (2005). Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences? World J Gastroenterol. 11 : 171-175.
56. Shimizu K, Onishi M, Sugata E, Sokuza Y, Mori C, Nishikawa T, Honoki K, Tsujiuchi T (2007). Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-defi cient L-amino acid-defi ned diet in rats. Cancer Sci. 98 : 1318-1322.
57. Shiojiri N, Niwa T, Sugiyama Y, Koike T (2006). Preferential expression of connexin37 and connexin40 in the endothelium of the portal veins during mouse liver development. Cell Tissue Res. 324 : 547-552.
58. Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C, Imazawa T, Hirose M (1999). The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofi brate hepatocarcinogenesis in the rat. Arch Toxicol. 73 : 373-380.
59. Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C, Takada K, Hirose M (2000). Liver tumor-promoting effect of beta-naphthofl avone, a strong CYP 1A1/2 inducer, and the relationship between CYP 1A1/2 induction and Cx32 decrease in its hepatocarcinogenesis in the rat. Toxicol Pathol. 28 : 540-547.
60. Snykers S, De Kock J, Rogiers V, Vanhaecke T (2009). In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells. 27 : 577-605.
61. Stumpel F, Ott T, Willecke K, Jungermann K (1998). Connexin 32 gap junctions enhance stimulation of glucose output by glucagon and noradrenaline in mouse liver. Hepatology. 28 : 1616-1620.
62. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, Willecke K (1997). High incidence of spontaneous and chemically induced liver tumors in mice defi cient for connexin32. Curr Biol. 7 : 713-716.
63. Temme A, Stumpel F, Sohl G, Rieber EP, Jungermann K, Willecke K, Ott T (2001). Dilated bile canaliculi and attenuated decrease of nerve-dependent bile secretion in connexin32-defi cient mouse liver. Pfl ugers Arch. 442 : 961-966.
64. Tsujiuchi T, Shimizu K, Itsuzaki Y, Onishi M, Sugata E, Fujii H, Honoki K (2007). CpG site hypermethylation of E-cadherin and connexin26 genes in hepatocellular carcinomas induced by a choline-defi cient L-amino acid-defi ned diet in rats. Mol Carcinog. 46 : 269-274.
65. Vinken M, Papeleu P, Snykers S, De Rop E, Henkens T, Chipman JK, Rogiers V, Vanhaecke T (2006a). Involvement of cell junctions in hepatocyte culture functionality. Crit Rev Toxicol. 36 : 299-318.
66. Vinken M, Vanhaecke T, Papeleu P, Snykers S, Henkens T, Rogiers V (2006b). Connexins and their channels in cell growth and cell death. Cell Signal. 18 : 592-600.
67. Vinken M, Henkens T, Vanhaecke T, Papeleu P, Geerts A, Van Rossen E, Chipman JK, Meda P, Rogiers V (2006c). Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. Toxicol Sci. 91 : 484-492.
68. Vinken M, Henkens T, Snykers S, Lukaszuk A, Tourwe D, Rogiers V, Vanhaecke T (2007). The novel histone deacetylase inhibitor 4-Me2N-BAVAH differentially affects cell junctions between primary hepatocytes. Toxicology. 236 : 92-102.
69. Vinken M, Henkens T, De Rop E, Fraczek J, Vanhaecke T, Rogiers V (2008). Biology and pathobiology of gap junctional channels in hepatocytes. Hepatology. 47 : 1077-1088.
70. Vinken M, De Rop E, Decrock E, De Vuyst E, Leybaert L, Vanhaecke T, Rogiers V (2009a). Epigenetic regulation of gap junctional intercellular communication: more than a way to keep cells quiet? Biochim Biophys Acta. 1795 : 53-61.
71. Vinken M, Doktorova T, Decrock E, Leybaert L, Vanhaecke T, Rogiers V (2009b). Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity. Crit Rev Biochem Mol Biol. 44 : 201-222.
72. Vinken M, Decrock E, De Vuyst E, De Bock M, Vandenbroucke RE, De Geest BG, Demeester J, Sanders NN, Vanhaecke T, Leybaert L, Rogiers V (2010). Connexin32 hemichannels contribute to the apoptotic-to-necrotic transition during Fas-mediated hepatocyte cell death. Cell Mol Life Sci. 67: 907-918.
73. Vinken M, Decrock E, De Vuyst E, Ponsaerts R, D' Hondt C, Bultynck G, Ceelen L, Vanhaecke T, Leybaert L, Rogiers V (2011). Connexins: sensors and regulators of cell cycling. Biochim Biophys Acta. 1815 : 13-25.
74. Vinken M, Decrock E, Vanhaecke T, Leybaert L, Rogiers V (2012). Connexin43 signaling contributes to spontaneous apoptosis in cultures of primary hepatocytes. Toxicol Sci. 125 : 175-186.
75. Willecke K, Heynkes R, Dahl E, Stutenkemper R, Hennemann H, Jungbluth S, Suchyna T, Nicholson BJ (1991). Mouse connexin37: cloning and functional expression of a gap junction gene highly expressed in lung. J Cell Biol. 114 : 1049-1057.
76. Yamaji S, Droggiti A, Lu SC, Martinez-Chantar ML, Warner A, Varela-Rey M (2011). S-Adenosylmethionine regulates connexins sub-types expressed by hepatocytes. Eur J Cell Biol. 90 : 312-322.
77. Yamaoka K, Nouchi T, Kohashi T, Marumo F, Sato C (2000). Expression of gap junction protein connexin 32 in chronic liver diseases. Liver. 20 : 104-107.
78. Yamasaki H (1990). Role of cell-cell communication in tumor suppression. Immunol Ser. 51 : 245-266.
79. Yamasaki H (1991). Aberrant expression and function of gap junctions during carcinogenesis. Environ Health Perspect. 93 : 191-197.
80. Yamasaki H (1996). Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutat Res. 365 : 91-105.
81. Yamasaki H, Krutovskikh V, Mesnil M, Columbano A, Tsuda H, Ito N (1993). Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect. 101 Suppl 5 : 191-197.
82. Yamasaki H, Naus CC (1996). Role of connexin genes in growth control. Carcinogenesis. 17 : 1199-1213.
83. Yang J, Ichikawa A, Tsuchiya T (2003). A novel function of connexin 32: marked enhancement of liver function in a hepatoma cell line. Biochem Biophys Res Commun. 307 : 80-85.
84. Zhang D, Kaneda M, Nakahama K, Arii S, Morita I (2007). Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication. Cancer Lett. 252 : 208-215.
85. Zhang JT, Nicholson BJ (1989). Sequence and tissue distribution of a second protein of hepatic gap junctions, Cx26, as deduced from its cDNA. J Cell Biol. 109 : 3391-3401.
86. Zhang M, Thorgeirsson SS (1994). Modulation of connexins during differentiation of oval cells into hepatocytes. Exp Cell Res. 213 : 37-42.